Armata Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,147 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 1-18 of 18 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-44887

SC 13D/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SC 13D/A

Filing date
04 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SC 13D/A

Filing date
11 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SC 13D/A

Filing date
10 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A, AMENDMENT #7

Filing date
01 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A (AMENDMENT NO. 6)

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A (AMENDMENT NO. 5)

Filing date
01 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D (AMENDMENT NO. 4)

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A, AMENDMENT #3

Filing date
17 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A, AMENDMENT #2

Filing date
27 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A, #1

Filing date
31 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-44887

SCHEDULE 13D

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-44887

SC 13D

Filing date
21 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

RANDAL J KIRK SC 13D/A NO 3 12-30-2016 (AMPLIPHI BIOSCIENCES CORP)

Filing date
30 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

RANDAL J KIRK SC 13D A NO 2 11-12-2016 (AMPLIPHI BIOSCIENCES CORP)

Filing date
16 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

RANDAL J. KIRK SC 13D A NO. 1 4-15-2016 (AMPLIPHI BIOSCIENCES CORPORATION)

Filing date
15 Apr 2016
Reporting date
Not listed
Next action
Verify source filing
SC 13D File 005-44887

RANDAL J KIRK SC 13D 3-16-2015 (AMPLIPHI BIOSCIENCES CORP)

Filing date
20 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-44887

SC 13D filing

Filing date
04 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .